Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy
- Ganan-Gomez, I.
- Yang, H.
- Ma, F.
- Montalban-Bravo, G.
- Thongon, N.
- Marchica, V.
- Richard-Carpentier, G.
- Chien, K.
- Manyam, G.
- Wang, F.
- Alfonso, A.
- Chen, S.
- Class, C.
- Kanagal-Shamanna, R.
- Ingram, J.P.
- Ogoti, Y.
- Rose, A.
- Loghavi, S.
- Lockyer, P.
- Cambo, B.
- Muftuoglu, M.
- Schneider, S.
- Adema, V.
- McLellan, M.
- Garza, J.
- Marchesini, M.
- Giuliani, N.
- Pellegrini, M.
- Wang, J.
- Walker, J.
- Li, Z.
- Takahashi, K.
- Leverson, J.D.
- Bueso-Ramos, C.
- Andreeff, M.
- Clise-Dwyer, K.
- Garcia-Manero, G.
- Colla, S.
- Show all authors +
ISSN: 1546-170X, 1078-8956
Year of publication: 2022
Volume: 28
Issue: 3
Pages: 557-567
Type: Article